LB Pharmaceuticals Inc. LBRX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
LB Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company specializing in the development of novel therapies for neuropsychiatric diseases, with a particular emphasis on conditions such as schizophrenia and bipolar depression. The company’s primary focus lies in advancing its lead product candidate, LB-102,…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees35
TickerLBRX
Statistics
Market Cap$855.5M
Revenue (TTM)$0
Net Income-$25.2M
Net Margin—
EPS$-3.13
P/E-9.36
P/S—
P/B2.15
EV/EBITDA-10.66
ROE-19.6%
Dividend Yield—
Price$29.84
Data: Twelve Data · Revenue = mcap / P/S